Paragon Care Limited (PXS) - Total Liabilities

Latest as of June 2024: €1.06 Billion EUR ≈ $1.24 Billion USD

Based on the latest financial reports, Paragon Care Limited (PXS) has total liabilities worth €1.06 Billion EUR (≈ $1.24 Billion USD) as of June 2024. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore how efficiently does Paragon Care Limited generate cash to assess how effectively this company generates cash.

Paragon Care Limited - Total Liabilities Trend (2014–2024)

This chart illustrates how Paragon Care Limited's total liabilities have evolved over time, based on quarterly financial data. Check PXS financial resilience to evaluate the company's liquid asset resilience ratio.

Paragon Care Limited Competitors by Total Liabilities

The table below lists competitors of Paragon Care Limited ranked by their total liabilities.

Company Country Total Liabilities
Etga Group Ltd
TA:ETGA
Israel ILA547.23 Million
Century Therapeutics Inc
NASDAQ:IPSC
USA $68.37 Million
Kangda International Environmental Company Limited
STU:27K
Germany €12.92 Billion
GRAPHENE MANUFACT.GROUP
F:0GF
Germany €26.24 Million
Detection Technology OY
HE:DETEC
Finland €25.68 Million
Ecomate Holdings Bhd
KLSE:0239
Malaysia RM65.68 Million
Merafe
JSE:MRF
South Africa ZAC1.10 Billion
Ryvu Therapeutics SA
WAR:RVU
Poland zł170.60 Million

Liability Composition Analysis (2014–2024)

This chart breaks down Paragon Care Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Paragon Care Limited stock valuation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 1.22 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 3.63 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.60 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Paragon Care Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Paragon Care Limited (2014–2024)

The table below shows the annual total liabilities of Paragon Care Limited from 2014 to 2024.

Year Total Liabilities Change
2024-06-30 €838.97 Million
≈ $980.84 Million
+326.82%
2023-06-30 €196.56 Million
≈ $229.80 Million
+0.96%
2022-06-30 €194.69 Million
≈ $227.61 Million
+14.25%
2021-06-30 €170.40 Million
≈ $199.22 Million
-5.27%
2020-06-30 €179.89 Million
≈ $210.31 Million
-6.25%
2019-06-30 €191.88 Million
≈ $224.33 Million
+6.83%
2018-06-30 €179.61 Million
≈ $209.98 Million
+115.45%
2017-06-30 €83.36 Million
≈ $97.46 Million
+11.12%
2016-06-30 €75.02 Million
≈ $87.71 Million
+275.05%
2015-06-30 €20.00 Million
≈ $23.38 Million
+128.80%
2014-06-30 €8.74 Million
≈ $10.22 Million
--

About Paragon Care Limited

F:PXS Germany Medical Distribution
Market Cap
$152.88 Million
€130.77 Million EUR
Market Cap Rank
#17574 Global
#1648 in Germany
Share Price
€0.08
Change (1 day)
-3.66%
52-Week Range
€0.08 - €0.24
All Time High
€0.45
About

Paragon Care Limited distributes medical equipment, devices, and consumable products in Australia, New Zealand, and Asia. The company designs, manufactures, and distributes reagent red blood cells, monoclonal blood grouping reagents, and ancillary products for immunohematology laboratories; offers ophthalmology and optometry, neonatal vision screening solutions, and procedural kits. It also provi… Read more